736MO Personalized, off-the-shelf KRAS neoantigen-specific immunotherapy for the treatment of advanced solid tumors: Clinical benefit associated with decreases in ctDNA (SLATE-KRAS)
Chrisann Kyi(Memorial Sloan Kettering Cancer Center), Alexander I. Spira(Virginia Cancer Institute), David P. Carbone(The Ohio State University Wexner Medical Center), Melissa L. Johnson(Sarah Cannon), Brian S. Henick(NewYork–Presbyterian Hospital), Britney Johnson(The University of Texas MD Anderson Cancer Center), Hossein Borghaei(Fox Chase Cancer Center), Amit Mahipal(Mayo Clinic in Arizona), J.R. Hecht, D. Catenacci, C-Y. Liao(University of Chicago), Ardaman Shergill(University of Chicago), Regan Memmott(The Ohio State University Wexner Medical Center), Carolyn J. Presley(The Ohio State University Wexner Medical Center), J. Jaroslavsky, Darius Schenk, K. Jooss, A.R. Ferguson, J.W. Goldman
Cited by 5
Abstract
Related Papers
No related papers found
Powered by citation graph analysis